BP1, an isoform of DLX4 homeoprotein, negatively regulates BRCA1 in sporadic breast cancer

International Journal of Biological Sciences

Volumn 6, Issue 5, 2010, Pages 513-524

  Kluk, Brian J ^a   Fu, Yebo ^a   Formolo, Trina A ^a   Zhang, Lei ^b   Hindle, Anne K ^a   Man, Yan Gao ^c   Siegel, Robert S ^a   Berg, Patricia E ^a   Deng, Chuxia ^d   McCaffrey, Timothy A ^a   Fu, Sidney W ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

BP1; BRCA1; Breast cancer; DLX4; Homeoprotein

Indexed keywords

EID: 77956961545     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.6.513     Document Type: Article

References (40)

1. [Internet]Society AC. Atlanta: American Cancer Society Inc. http://www.cancer.org.
2. Institute NC: Genetics of breast and ovarian cancer. Bethesda, MD: Institute NC. 2005.
3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266(5182):66-71.
4. Smith SA, Easton DF, Evans DG, Ponder BA: Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992, 2(2):128-131.
5. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y. et al.: BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994, 266(5182):120-122.
6. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT.: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995, 9(4):444-450.
7. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D. et al.: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 1999, 21(2):236-240.
8. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, Jensen RA.: Growth retardation and tumour inhibition by BRCA1. Nat Genet 1996, 12(3):298-302.
9. Dobrovic A, Simpfendorfer D: Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 1997, 57(16):3347-3350.
10. Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W, Archer TK.: CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 1998, 16(9):1161-1169.
11. Catteau A, Harris WH, Xu CF, Solomon E: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 1999, 18(11):1957-1965.
12. Baldassarre G, Battista S, Belletti B, Thakur S, Pentimalli F, Trapasso F, Fedele M, Pierantoni G, Croce CM, Fusco A.: Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol Cell Biol 2003, 23(7):2225-2238.
13. Wang C, Fan S, Li Z, Fu M, Rao M, Ma Y, Lisanti MP, Albanese C, Katzenellenbogen BS, Kushner PJ et al.: Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Res 2005, 65(15):6557-6567.
14. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM.: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997, 90(3):425-435.
15. Andres JL, Fan S, Turkel GJ, Wang JA, Twu NF, Yuan RQ, Lamszus K, Goldberg ID, Rosen EM.: Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene 1998, 16(17):2229-2241.
16. Fan S, Twu NF, Wang JA, Yuan RQ, Andres J, Goldberg ID, Rosen EM.: Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation. Int J Cancer 1998, 77(4):600-609.
17. MacLachlan TK, Dash BC, Dicker DT, El-Deiry WS: Repression of BRCA1 through a feedback loop involving p53. J Biol Chem 2000, 275(41):31869-31875.
18. Hsu LC, White RL: BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci U S A 1998, 95(22):12983-12988.
19. Lotti LV, Ottini L, D'Amico C, Gradini R, Cama A, Belleudi F, Frati L, Torrisi MR, Mariani-Costantini R. Subcellular localization of the BRCA1 gene product in mitotic cells. Genes Chromosomes Cancer 2002, 35(3):193-203.
20. Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 1999, 3(3):389-395.
21. Hsu LC, Doan TP, White RL: Identification of a gamma-tubulin-binding domain in BRCA1. Cancer Res 2001, 61(21):7713-7718.
22. Schlegel BP, Starita LM, Parvin JD: Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells. Oncogene 2003, 22(7):983-991.
23. Starita LM, Machida Y, Sankaran S, Elias JE, Griffin K, Schlegel BP, Gygi SP, Parvin JD. BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number. Mol Cell Biol 2004, 24(19):8457-8466.
24. Abate-Shen C: Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2002, 2(10):777-785.
25. Chase MB, Fu S, Haga SB, Davenport G, Stevenson H, Do K, Morgan D, Mah AL, Berg PE. BP1, a homeodomain-containing isoform of DLX4, represses the beta-globin gene. Mol Cell Biol 2002, 22(8):2505-2514.
26. Fu S, Stevenson H, Strovel JW, Haga SB, Stamberg J, Do K, Berg PE. Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene. Gene 2001, 278(1-2):131-139.
27. Haga SB, Fu S, Karp JE, Ross DD, Williams DM, Hankins WD, Behm F, Ruscetti FW, Chang M, Smith BD et al. BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia 2000, 14(11):1867-1875.
28. Stevenson HS, Fu SW, Pinzone JJ, Rheey J, Simmens SJ, Berg PE. BP1 transcriptionally activates bcl-2 and inhibits TNFalpha-induced cell death in MCF7 breast cancer cells. Breast Cancer Res 2007, 9(5):R60.
29. Fu SW, Schwartz A, Stevenson H, Pinzone JJ, Davenport GJ, Orenstein JM, Gutierrez P, Simmens SJ, Abraham J, Poola I.et al. Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer. Breast Cancer Res 2003, 5(4):R82-87.
30. Sheikh MS, Garcia M, Pujol P, Fontana JA, Rochefort H: Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion Metastasis 1994, 14(1-6):329-336.
31. Fu Y, Lian Y, Kim KS, Zhang L, Hindle AK, Brody F, Siegel RS, McCaffrey TA, Fu SW.: BP1 Homeoprotein Enhances Metastatic Potential in ER-negative Breast Cancer. J Cancer 2010, 1(1):54-62.
32. Man YG, Fu SW, Schwartz A, Pinzone JJ, Simmens SJ,Berg PE.: Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion. Breast Cancer Res Treat 2005, 90(3):241-247.
33. Song Y, Dang C, Fu Y, Lian Y, Hottel J, Li X, McCaffrey T, Fu SW.: Genome-wide analysis of BP1 transcriptional targets in breast cancer cell line Hs578T. Int J Biol Sci 2009, 5(1):1-12.
34. Man YG, Ball WD, Culp DJ, Hand AR, Moreira JE: Persistence of a perinatal cellular phenotype in submandibular glands of adult rat. J Histochem Cytochem 1995, 43(12):1203-1215.
35. Man YG: A simple epitope retrieval method without the use of microwave oven or enzyme digestion. Applied Immunohistochemistry 1996, 4:139-141.
36. Suen TC, Goss PE: Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 Bi-directional promoter. J Biol Chem 1999, 274(44):31297-31304.
37. Thakur S, Croce CM: Positive regulation of the BRCA1 promoter. J Biol Chem 1999, 274(13):8837-8843.
38. Wang A, Schneider-Broussard R, Kumar AP, MacLeod MC, Johnson DG.: Regulation of BRCA1 expression by the Rb-E2F pathway. J Biol Chem 2000, 275(6):4532-4536.
39. Suen TC, Goss PE: Identification of a novel transcriptional repressor element located in the first intron of the human BRCA1 gene. Oncogene 2001, 20(4):440-450.
40. Wardrop SL, Brown MA: Identification of two evolutionarily conserved and functional regulatory elements in intron 2 of the human BRCA1 gene. Genomics 2005, 86(3):316-328.